ID
45433
Beskrivning
Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Uterine Cervical Neoplasms,Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000628 In this study, we used shallow whole genome, exome, and RNA sequencing to genomically and transcriptomically characterize a cervical squamous carcinoma lesion metastatic to the lung and to detect and analyze HPV infection in the same sample.
Länk
Nyckelord
Versioner (1)
- 2022-11-29 2022-11-29 - Chiara Middel
Rättsinnehavare
Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA
Uppladdad den
29 november 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000628 Characterization of a Metastatic Cervical Cancer Using NGS
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
Similar models
Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- StudyEvent: SEV1
- Subject ID, consent group, and research type of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, sample ID, sample use variable obtained from participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Subject ID, age, sex, and race of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type, tumor status, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants with cervical squamous carcinoma and involved in the "Characterization of a Metastatic Cervical Cancer Patient and HPV18 Integration Using Next Generation Sequencing" project.
C0242481 (UMLS CUI [1,2])
C0035168 (UMLS CUI [1,2])
C1524063 (UMLS CUI [1,3])
C1511726 (UMLS CUI [1,4])